Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.
"This article will serve as a landmark reference for navigating short-term labor challenges in radiology," explains one editorial about the suggestions.
At scientific journals focused on medical imaging, 82% of editors-in-chief and 30% of editorial board members receive financial compensation for these side jobs.
The FDA has approved a CT guidance system for interventional radiologists performing percutaneous procedures with robotics. And the European Union has greenlit a family of mobile CT scanners.
A telehealth practice active in all 50 states has hired a similarly sprawling behavioral-health consultancy to provide physicians with pro-wellbeing, anti-burnout counseling and related services.
A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.
An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.
Prior to the final proposal’s release, the American College of Radiology reached out to CMS to offer its recommendations on payment rates for five out of the six the new codes.